Background Clinical top features of epidermal growth factor receptor (EGFR) mutations: L858R, deletions in exon 19, T790M, insertions in exon 20, G719X, and L861X in non-small-cell lung cancer (NSCLC) are well-known. as well as the median progression-free success was 6.2 months. All 5 sufferers who got delE709-T710insD were nonresponders to TKI remedies. Bottom NSC 131463… Continue reading Background Clinical top features of epidermal growth factor receptor (EGFR) mutations: